Abcam (ABCM) Stock Price, News & Analysis

Company Overview

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Key Stats

• Today's Range: $23.99 to $23.99
• 50-Day Range: $23.07 to $23.99
• 52-Week Range: $12.48 to $25.32
• Volume: 3,300 shs
• Average Volume: 3.08 million shs
• Market Capitalization: $5.50 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABCM Stock Analysis - Frequently Asked Questions

When did Abcam IPO?

Abcam (ABCM) raised $149 million in an initial public offering on Thursday, October 22nd 2020. The company issued 9,000,000 shares at $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair acted as the underwriters for the IPO.

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Abcam investors own include HubSpot (HUBS), Meta Platforms (META), Netflix (NFLX), Tesla (TSLA), Advanced Micro Devices (AMD), Bank of America (BAC) and ConocoPhillips (COP).

Company Calendar

• Today: 4/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ABCM
• CIK: 1492074
• Web: www.abcam.com
• Phone: 44-0-12-2369-6000
• Fax: N/A
• Employees: 1,760
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 54.52
• P/E Growth: 2.19
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.35
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $379.70 million
• Price / Sales: 14.49
• Cash Flow: $0.60 per share
• Price / Cash Flow: 40.17
• Book Value: $3.92 per share
• Price / Book: 6.12

Miscellaneous

• Outstanding Shares: 229,272,000
• Free Float: 213,842,000
• Market Cap: $5.50 billion
• Optionable: Optionable
• Beta: 0.86